IFM Investors Pty Ltd increased its stake in Waters Corporation (NYSE:WAT - Free Report) by 6.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,054 shares of the medical instruments supplier's stock after acquiring an additional 773 shares during the period. IFM Investors Pty Ltd's holdings in Waters were worth $4,338,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Aster Capital Management DIFC Ltd purchased a new position in shares of Waters in the 4th quarter valued at $28,000. Steward Partners Investment Advisory LLC raised its stake in shares of Waters by 129.3% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 53 shares during the period. Whipplewood Advisors LLC raised its stake in shares of Waters by 5,200.0% in the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after acquiring an additional 104 shares during the period. Murphy & Mullick Capital Management Corp purchased a new position in shares of Waters in the 4th quarter valued at $42,000. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Waters by 54.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock valued at $46,000 after acquiring an additional 44 shares during the period. 94.01% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
WAT has been the topic of a number of research reports. KeyCorp raised shares of Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 target price on the stock in a research note on Monday, March 31st. Bank of America raised their target price on shares of Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. UBS Group cut their target price on shares of Waters from $415.00 to $360.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 7th. Barclays dropped their price target on shares of Waters from $400.00 to $350.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Finally, Sanford C. Bernstein set a $400.00 price target on shares of Waters and gave the stock an "outperform" rating in a research note on Wednesday, April 16th. Nine analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Waters presently has an average rating of "Moderate Buy" and an average price target of $388.00.
Get Our Latest Stock Analysis on Waters
Waters Price Performance
Shares of WAT stock opened at $350.22 on Monday. The firm has a market cap of $20.84 billion, a P/E ratio of 31.78, a P/E/G ratio of 3.46 and a beta of 1.10. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.81 and a quick ratio of 1.28. Waters Corporation has a 1-year low of $279.24 and a 1-year high of $423.56. The firm has a fifty day moving average of $349.05 and a two-hundred day moving average of $364.28.
Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.03. The company had revenue of $661.71 million during the quarter, compared to analyst estimates of $655.50 million. Waters had a net margin of 22.02% and a return on equity of 41.70%. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period last year, the business earned $2.21 EPS. As a group, research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.
Waters Profile
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Recommended Stories
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
